44 results
8-K/A
EX-99.2
CRVO
CervoMed Inc
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
to cover any losses experienced as a result of a cybersecurity incident.
Unfavorable global economic conditions could adversely affect the Company’s
424B3
2iglyh
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
nuf1d0plsf
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
dn7wxg2xvz5nn f77myc
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
vs4wumv8no4ff
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
o171ts
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-1.1
ty90kolk64xaimczdu4
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-1.1
x1b 7jy8toa5t6le
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-10.1
ltly3c6n6 hxhie6qi
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-10.1
1jin33 5zi30i
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-10.2
bksmub75r3o a246mjjg
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-10.1
0pxi xathvmo71rfj
28 May 19
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
4:44pm